Please assess the completion status of the following clinical trial:

Trial Title: An Open-Label Trial of Dexlansoprazole 60mg for the Relief of Heartburn During the Fasting Month of Ramadan

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Individuals 18-75 years old~* Fasting in Ramadan~* No daily PPI use~* Individuals willing to sign consent form~* Patients owning a smartphone and able to use a smartphone application~Exclusion Criteria:~* Known erosive GERD on PPI~* Pregnant females~* Prior gastric surgery~* Long standing diabetes mellitus (≥10 years of disease)~* Frequent NSAID use (\>3x/week)~* Morbid obesity (BMI\>35)~* History of recent (\<6 months) upper GI bleeding~* Patients who do not own a smartphone or who cannot use a smartphone application~* Known allergy to PPIs~* Known history of poor compliance or adherence and active psychological problems which might impact adherence

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 34 patients will be assigned to take Dexlansoprazole 60mg over the 2nd, 3rd, and 4th weeks of the month of Ramadan.

Based on this trial design, predict the completion outcome and termination type (if applicable).